Thank you for that question, which is very interesting.
I have a lot to tell you, but I'll try to summarize my comments.
I've extensively studied the advance medical directives regime, and, as you know, very few people have had access to it. We're talking about slightly more than 100,000 persons in Quebec, so it isn't an extensively used regime.
I don't share x Ms. Chalifoux' view. I think advance medical directives do cover strokes. We should separate that and stick to diagnoses of neurocognitive disorders.
As for support, that's a very interesting question, but I don't think we can do without a discussion beforehand. There's an implementation problem. A read flag is raised because of what was said, but there was no discussion.
According to some recent studies conducted in 2022, the discussion is far more important for patients than the form. Consequently, it's important to discuss various scenarios with them and to ascertain their values. I think it's important to state in advance that the process won't be limited to the form and that the basis of the decision will be explained.
It's also important that the family be present.
I really view this support as being divided into two parts.